CRISPR Therapeutics (SRSP) stock gains as the company gets a new Overweight rating from J.P. Morgan thanks to its therapeutic ...

A genome-editing technique known as prime editing holds potential for treating many diseases by transforming faulty genes into functional ones.

CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...

By Michelle Yang Researchers from Mie University in Japan used the gene editing tool CRISPR to remove the extra chromosome 21, the copy responsible for Down syndrome. Courtesy of digitale.de via ...

Researchers engineered and screened dozens of base editors to precisely target a single mutation without editing other portions of the DNA.

More than a decade ago, scientists harnessed a bacterial molecular machine that identifies and cuts specific sections of DNA, ...

LONDON, GREATER LONDON, UNITED KINGDOM, September 10, 2025 /EINPresswire.com/ -- How Big Is The Cas12 Protein Market In 2025? In the past few years, the market size for the Cas12 protein has been ...

The researchers from the Belgian Federal Institute Sciensano, as part of the DARWIN project, have developed a groundbreaking proof-of-concept for ...

CRISPR has the power to correct genetic mutations, but current delivery methods are either unsafe or inefficient, keeping the technology from reaching its full medical potential. With the power to ...

When scientists discovered how bacteria protect themselves against viral invaders, called phages, in the early 2000s, little did they know they'd stumbled upon a revolutionary tool researchers could ...

When scientists discovered how bacteria protect themselves against viral invaders, called phages, in the early 2000s, little did they know they'd ...